To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, November 1, 2022
Prostate cancer: Identifying drug resistance
Prostate cancer: Identifying drug
resistance
Mayo Clinic researchers have identified critical genomic changes
in response to abiraterone acetate/prednisone.
No comments:
Post a Comment